| GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas RG Majzner, S Ramakrishna, KW Yeom, S Patel, H Chinnasamy, ... Nature 603 (7903), 934-941, 2022 | 568 | 2022 |
| Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial J Fangusaro, A Onar-Thomas, TY Poussaint, S Wu, AH Ligon, ... The lancet oncology 20 (7), 1011-1022, 2019 | 453 | 2019 |
| Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors S Gholamin, SS Mitra, AH Feroze, J Liu, SA Kahn, M Zhang, R Esparza, ... Science translational medicine 9 (381), eaaf2968, 2017 | 399 | 2017 |
| Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome T Tihan, PG Fisher, JL Kepner, C Godfraind, RD McComb, PT Goldthwaite, ... Journal of neuropathology and experimental neurology 58 (10), 1061-1068, 1999 | 370 | 1999 |
| Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma M Monje, SS Mitra, ME Freret, TB Raveh, J Kim, M Masek, JL Attema, G Li, ... Proceedings of the National Academy of Sciences 108 (11), 4453-4458, 2011 | 359 | 2011 |
| Early detection of cancer: past, present, and future JD Schiffman, PG Fisher, P Gibbs American Society of Clinical Oncology Educational Book 35 (1), 57-65, 2015 | 353 | 2015 |
| Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies ML Monje, H Vogel, M Masek, KL Ligon, PG Fisher, TD Palmer Annals of Neurology: Official Journal of the American Neurological …, 2007 | 350 | 2007 |
| MRI surrogates for molecular subgroups of medulloblastoma S Perreault, V Ramaswamy, AS Achrol, K Chao, TT Liu, D Shih, M Remke, ... American Journal of Neuroradiology 35 (7), 1263-1269, 2014 | 343 | 2014 |
| Advances toward an understanding of brainstem gliomas SS Donaldson, F Laningham, PG Fisher Journal of Clinical Oncology 24 (8), 1266-1272, 2006 | 303 | 2006 |
| Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas JD Schiffman, JG Hodgson, SR VandenBerg, P Flaherty, MYC Polley, ... Cancer research 70 (2), 512-519, 2010 | 296 | 2010 |
| Profile of daily life in children with brain tumors: an assessment of health-related quality of life SR Bhat, TL Goodwin, TM Burwinkle, MF Lansdale, GV Dahl, SL Huhn, ... Journal of clinical oncology 23 (24), 5493-5500, 2005 | 278 | 2005 |
| A clinicopathologic reappraisal of brain stem tumor classification: Identification of pilocytic astrocytoma and fibrillary astrocytoma as distinct entities PG Fisher, SN Breiter, BS Carson, MD Wharam, JA Williams, JD Weingart, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 265 | 2000 |
| Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study CS McGuire, KL Sainani, PG Fisher Journal of neurosurgery 110 (4), 725-729, 2009 | 263 | 2009 |
| Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial GW Robinson, VA Rudneva, I Buchhalter, CA Billups, SM Waszak, ... The Lancet Oncology 19 (6), 768-784, 2018 | 221 | 2018 |
| Outcome analysis of childhood low‐grade astrocytomas PG Fisher, T Tihan, PT Goldthwaite, MD Wharam, BS Carson, ... Pediatric blood & cancer 51 (2), 245-250, 2008 | 215 | 2008 |
| Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis V Ramaswamy, T Hielscher, SC Mack, A Lassaletta, T Lin, KW Pajtler, ... Journal of clinical oncology 34 (21), 2468-2477, 2016 | 207 | 2016 |
| MARRVEL: integration of human and model organism genetic resources to facilitate functional annotation of the human genome J Wang, R Al-Ouran, Y Hu, SY Kim, YW Wan, MF Wangler, S Yamamoto, ... The American Journal of Human Genetics 100 (6), 843-853, 2017 | 191 | 2017 |
| Loss of SMARCB1/INI1 expression in poorly differentiated chordomas BC Mobley, JK McKenney, CD Bangs, K Callahan, KW Yeom, ... Acta neuropathologica 120, 745-753, 2010 | 183 | 2010 |
| The undiagnosed diseases network: accelerating discovery about health and disease RB Ramoni, JJ Mulvihill, DR Adams, P Allard, EA Ashley, JA Bernstein, ... The American Journal of Human Genetics 100 (2), 185-192, 2017 | 172 | 2017 |
| Phase II trial assessing the ability of neoadjuvant chemotherapy with or without second-look surgery to eliminate measurable disease for nongerminomatous germ cell tumors: a … S Goldman, E Bouffet, PG Fisher, JC Allen, PL Robertson, PJ Chuba, ... Journal of Clinical Oncology 33 (22), 2464-2471, 2015 | 166 | 2015 |
Michelle Monje-DeisserothProfessor of Neurology, Howard Hughes Medical Institute Investigator, Stanford University在 stanford.edu 的电子邮件经过验证
